Tolmar Pharmaceuticals
UEI: F5YWK7NR9LA6
• CAGE: 72T50
Overview
Awardee Type
Parent
Company Description
Tolmar is a pharmaceutical company focused on the development, approval and commercialization of specialty pharmaceutical products in the therapeutic areas of urology and oncology.
Name
Tolmar Pharmaceuticals
Website
Headquarters
Fort Collins, CO
United States
United States
Federal recipient
TOLMAR PHARMACEUTICALS INC
(UEI F5YWK7NR9LA6, CAGE 72T50)
is headquartered in Fort Collins CO.
Its primary registered NAICS is 325412 Pharmaceutical Preparation Manufacturing.
The corporation
was founded in January 2014 and
federally registered in
March 2014.
Federal Registration and Certifications
Legal Name
TOLMAR PHARMACEUTICALS INC
UEI
F5YWK7NR9LA6
CAGE Code
72T50
Primary NAICS
SBA Certifications
None
Self Certifications
None
Entity Structure
Corporate Entity (Not Tax Exempt)
Purpose of Registration
Federal Contracts and Assistance
Date Founded
Jan. 27, 2014
Initial Registration
March 4, 2014
Last Registration
Oct. 23, 2023
Registration Activation
Oct. 26, 2022
Registration Expiration
Oct. 23, 2023
Fiscal Year End
December 31
Reported Entity Types
Foreign Owned
For Profit Organization
For Profit Organization
State of Incorporation
DE
Country of Incorporation
USA
Employees
751-1000
Reported NAICS
Accepts Credit Cards
No
People
Vendor contacts at Tolmar Pharmaceuticals
GSA Schedules and Price Lists
- Tolmar Pharmaceuticals
- PoP: 5/31/16 - 9/14/21 (Ended)